## Abstract ## __Background.__ Five‐aminolaevulinic acid (ALA) and its derivatives act as precursors of the photosensitizer protoporphyrin IX (PpIX). In this study, the effect of photodynamic therapy (PDT) with hexenyl ester of ALA (ALA‐hx) was examined in a human oral squamous cell carcinoma, YD1
Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells
✍ Scribed by Bachor, R. ;Reich, E. ;R�ck, A. ;Hautmann, R.
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 871 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In a recent clinical study, we reported a selective uptake of hypericin in superficial bladder tumors. The results suggested that hypericin, a potent photosensitizer, could be used not only for diagnosis but also for photodynamic therapy (PDT) of superficial bladder tumors. In the prese
Photodynamic (PDT) therapy is a relatively new technique with unique properties that make it attractive for the local treatment of superficial epithelial disorders. The objective of this study was to investigate the clinical response of PDT with the photosensitizing agent 5-aminolevulinic acid (5-AL
BACKGROUND. Delta-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) is currently being investigated for the treatment of prostate diseases. In this study, we evaluate 1) the in vitro production of protoporphyrin IX (PPIX) (the active photosensitizing agent of ALA-mediated PDT) by two dif
## Abstract Whole‐bladder wall photodynamic therapy (PDT) is a promising treatment for carcinoma __in situ__ (CIS) and diffuse premalignant changes of the bladder. After the results of our clinical studies showing that intravesical hypericin selectively accumulates in superficial bladder tumors, we